La variabilité glycémique asymptomatique: comment l'évaluer et quelle est son incidence clinique ?

Service, 1980, Characteristics of glycemic stability, Diabetes Care, 3, 58, 10.2337/diacare.3.1.58 Molnar, 1972, Day-to-day variation of continuously monitored glycaemia a further measure of diabetic instability, Diabetologia, 8, 342, 10.1007/BF01218495 Hansen, 1982, Rapid oscillations in plasma insulin, glucagon, and glucose in obese and normal weight humans, J Clin Endocrinol Metab, 54, 785, 10.1210/jcem-54-4-785 Bantle, 1983, Postprandial glucose and insulin responses to meals containing different carbohydrates in normal and diabetic subjects, N Engl J Med, 309, 7, 10.1056/NEJM198307073090102 Service, 1983, Effects of size, time of day and sequence of meal ingestion on carbohydrate tolerance in normal subjects, Diabetologia, 25, 316, 10.1007/BF00253193 Van Cauter, 1989, Nocturnal decrease in glucose tolerance during constant glucose infusion, J Clin Endocrinol Metab, 69, 604, 10.1210/jcem-69-3-604 Service, 1987, Measurements of glucose control, Diabetes Care, 10, 225, 10.2337/diacare.10.2.225 1995, The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial, Diabetes, 44, 968, 10.2337/diabetes.44.8.968 Ceriello, 1998, The emerging role of post-prandial hyperglycaemic spikes in the pathogenesis of diabetic complications, Diabet Med, 15, 188, 10.1002/(SICI)1096-9136(199803)15:3<188::AID-DIA545>3.0.CO;2-V Bonora, 2001, Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes the epidemiological evidence, Diabetologia, 44, 2107, 10.1007/s001250100020 Temelkova-Kurktschiev, 2000, Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level, Diabetes Care, 23, 1830, 10.2337/diacare.23.12.1830 Liljenquist, 1977, Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man, J Clin Invest, 59, 369, 10.1172/JCI108649 Selam, 2000, How to measure glycemic instability ?, Diabetes Metab, 26, 148 Koivisto, 1980, Alterations in insulin absorption and in blood glucose control associated with varying insulin injection sites in diabetic patients, Ann Intern Med, 92, 59, 10.7326/0003-4819-92-1-59 Service, 1970, Mean amplitude of glycemic excursions, a measure of diabetic instability, Diabetes, 19, 644, 10.2337/diab.19.9.644 Schlichtkrull, 1965, The M-value, an index of blood-sugar control in diabetes, Acta Med Scan, 177, 95, 10.1111/j.0954-6820.1965.tb01810.x Mirouze, 1963, Coefficient d'efficacité insulinique coefficient M de Schlichtkrull corrigé et simplifié par la technique de l'enregistrement glycémique continu, Diabete, 267 Kovatchev, 1997, Symmetrization of the blood glucose measurement scale and its applications, Diabetes Care, 20, 1655, 10.2337/diacare.20.11.1655 Kovatchev, 1998, Assessment of risk for severe hypoglycemia among adults with IDDM validation of the low blood glucose index, Diabetes Care, 21, 1870, 10.2337/diacare.21.11.1870 Catargi, 2000, Glucose profiles in a type 1 diabetic patient successively treated with CSII using regular insulin, lispro and an implantable insulin pump, Diabetes Metab, 26, 210 Catargi, 2001, A randomized study comparing blood glucose control and risk of severe hypoglycemia achieved by non-programmable versus programmable external insulin pumps, Diabetes Metab, 27, 323 Service, 2001, The relation of glycaemia to the risk of development and progression of retinopathy in the Diabetic Control and Complications Trial, Diabetologia, 44, 1215, 10.1007/s001250100635 Blood glucose control and the evolution of diabetic retinopathy and albuminuria, 1984, A preliminary multicenter trial. The Kroc Collaborative Study Group, N Engl J Med, 311, 365 Arias, 1985, Incidence of hypoglycemic episodes in diabetic patients under continuous subcutaneous insulin infusion and intensified conventional insulin treatment assessment by means of semiambulatory 24-hour continuous blood glucose monitoring, Diabetes Care, 8, 134, 10.2337/diacare.8.2.134 Selam, 1992, Randomized comparison of metabolic control achieved by intraperitoneal insulin infusion with implantable pumps versus intensive subcutaneous insulin therapy in type I diabetic patients, Diabetes Care, 15, 53, 10.2337/diacare.15.1.53 Hanaire-Broutin, 1995, Feasibility of intraperitoneal insulin therapy with programmable implantable pumps in IDDM. A multicenter study. The EVADIAC Study Group. Evaluation dans le Diabete du Traitement par Implants Actifs, Diabetes Care, 18, 388, 10.2337/diacare.18.3.388 Zinman, 1997, Insulin lispro in CSII results of a double-blind crossover study, Diabetes, 46, 440, 10.2337/diabetes.46.3.440 Melki, 1998, Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps, Diabetes Care, 21, 977, 10.2337/diacare.21.6.977 Colombel, 1999, Improvement of blood glucose control in Type 1 diabetic patients treated with lispro and multiple NPH injections, Diabet Med, 16, 319, 10.1046/j.1464-5491.1999.00077.x Shichiri, 2000, Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients, Diabetes Care, 23, B21 Cox, 1994, Frequency of severe hypoglycemia in insulin-dependent diabetes mellitus can be predicted from self-monitoring blood glucose data, J Clin Endocrinol Metab, 79, 1659, 10.1210/jc.79.6.1659 Kovatchev, 2000, Episodes of severe hypoglycemia in type 1 diabetes are preceded and followed within 48 hours by measurable disturbances in blood glucose, J Clin Endocrinol Metab, 85, 4287, 10.1210/jc.85.11.4287